Deficiency of ERβ and prostate tumorigenesis in FGF8b transgenic mice
Authors:
- Teresa EloTETeresa Elo
- Sari MäkeläSMSari Mäkelä
- Pirkko HärkönenPHPirkko Härkönen
- 17 June 2014
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 21 (4) , 677-690
Abstract
Estrogens contribute to the development and growth of the prostate and are implicated in prostate tumorigenesis. In their target tissues, estrogens mediate their effects via estrogen receptor α (ERα (ESR1)) and β (ERβ (ESR2)). Hyperplasia and decreased differentiation of epithelial cells in the prostate have been reported inERβknockout (BERKO) mice. Herein, we studied the effect of ERβ deficiency on prostate tumorigenesis by crossing BERKOFVBmice with prostate-targeted human fibroblast growth factor 8b transgenic (FGF8b-Tg) mice. Consistent with results described in our previous report, the prostates of 1-year-oldFGF8b-Tg mice displayed stromal aberrations, prostatic intraepithelial neoplasia (mPIN) lesions, inflammation, and occasionally cancer. The prostates of BERKOFVBmice exhibited mild epithelial hypercellularity and inflammation. The prostate phenotypes ofFGF8b-Tg-BERKOFVBmice closely resembled those ofFGF8b-Tg mice. However, mucinous metaplasia, indicated by Goblet-like cells in the epithelium, was significantly more frequent in the prostates ofFGF8b-Tg-BERKOFVBmice when compared withFGF8b-Tg mice. Furthermore, compared withFGF8b-Tg mice, there was a tendency for increased frequency of inflammation but milder hyperplasias in the prostate stroma ofFGF8b-Tg-BERKOFVBmice. The expression levels of mRNAs forFGF8b-regulated genes including osteopontin (Spp1), connective tissue growth factor (Ctgf), fibroblast growth factor receptors (Fgfrs), and steroid hormone receptors and cytokines were similar in the prostates ofFGF8b-Tg andFGF8b-Tg-BERKOFVBmice. Our results indicate that ERβ plays a role in the differentiation of the prostatic epithelium and, potentially, in the defensive mechanism required for protection against inflammation but do not support a direct tumor-suppressive function of ERβ in the prostate ofFGF8b-Tg mice.Keywords
This publication has 54 references indexed in Scilit:
- Current concepts and significance of estrogen receptor β in prostate cancerSteroids, 2012
- Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancerProceedings of the National Academy of Sciences, 2011
- Differential Fibroblast Growth Factor 8 (FGF8)-Mediated Autoregulation of Its Cognate Receptors, Fgfr1 and Fgfr3, in Neuronal Cell LinesPLOS ONE, 2010
- Estrogen receptor–β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediatedProceedings of the National Academy of Sciences, 2010
- The role of estrogens and estrogen receptors in normal prostate growth and diseaseSteroids, 2008
- Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERβ-null mutantProceedings of the National Academy of Sciences, 2008
- Genetic background influences murine prostate gene expression: implications for cancer phenotypesGenome Biology, 2007
- Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signalingProceedings of the National Academy of Sciences, 2006
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 2006
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996